Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache

Alireza Baratloo, Sara Arab Bafarani, Mohammad Mehdi Forouzanfar, Behrooz Hashemi, Benjamin W. Friedman, Ali Abdalvand

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this study was to determine if intravenous caffeine is as effective as intravenous ketorolac for the treatment of moderate to severe migraine headaches. Eligible patients randomly received 60 mg caffeine citrate or 60 mg ketorolac infused intravenously. Their pain score were measured at baseline, one hour and two hours after infusion. Therapeutic success was defined as decreasing of at least 3 points on the pain score. In total 110 patients were enrolled (75.5% women). Therapeutic success after 60 min was achieved by 63.6% of patients in the caffeine and 70.1% of patients in the ketorolac group (p = 0.23). After 120 min, 87.3% of the caffeine group and 83.6% of the ketorolac group achieved therapeutic success (p = 0.49). In this multi-center, randomized double blind study, intravenous caffeine was as effective as intravenous ketorolac for first line abortive management of acute migraine.

Original languageEnglish (US)
Pages (from-to)428-432
Number of pages5
JournalBangladesh Journal of Pharmacology
Volume11
Issue number2
DOIs
StatePublished - 2016

Fingerprint

Ketorolac
Caffeine
Migraine Disorders
Pain
Therapeutics
Double-Blind Method

ASJC Scopus subject areas

  • Pharmacology

Cite this

Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache. / Baratloo, Alireza; Bafarani, Sara Arab; Forouzanfar, Mohammad Mehdi; Hashemi, Behrooz; Friedman, Benjamin W.; Abdalvand, Ali.

In: Bangladesh Journal of Pharmacology, Vol. 11, No. 2, 2016, p. 428-432.

Research output: Contribution to journalArticle

Baratloo, Alireza ; Bafarani, Sara Arab ; Forouzanfar, Mohammad Mehdi ; Hashemi, Behrooz ; Friedman, Benjamin W. ; Abdalvand, Ali. / Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache. In: Bangladesh Journal of Pharmacology. 2016 ; Vol. 11, No. 2. pp. 428-432.
@article{a1c3c23f4a0c4e64b14185149fb7888d,
title = "Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache",
abstract = "The aim of this study was to determine if intravenous caffeine is as effective as intravenous ketorolac for the treatment of moderate to severe migraine headaches. Eligible patients randomly received 60 mg caffeine citrate or 60 mg ketorolac infused intravenously. Their pain score were measured at baseline, one hour and two hours after infusion. Therapeutic success was defined as decreasing of at least 3 points on the pain score. In total 110 patients were enrolled (75.5{\%} women). Therapeutic success after 60 min was achieved by 63.6{\%} of patients in the caffeine and 70.1{\%} of patients in the ketorolac group (p = 0.23). After 120 min, 87.3{\%} of the caffeine group and 83.6{\%} of the ketorolac group achieved therapeutic success (p = 0.49). In this multi-center, randomized double blind study, intravenous caffeine was as effective as intravenous ketorolac for first line abortive management of acute migraine.",
author = "Alireza Baratloo and Bafarani, {Sara Arab} and Forouzanfar, {Mohammad Mehdi} and Behrooz Hashemi and Friedman, {Benjamin W.} and Ali Abdalvand",
year = "2016",
doi = "10.3329/bjp.v11i2.26333",
language = "English (US)",
volume = "11",
pages = "428--432",
journal = "Bangladesh Journal of Pharmacology",
issn = "1991-007X",
publisher = "Bangladesh Pharmacological Society",
number = "2",

}

TY - JOUR

T1 - Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache

AU - Baratloo, Alireza

AU - Bafarani, Sara Arab

AU - Forouzanfar, Mohammad Mehdi

AU - Hashemi, Behrooz

AU - Friedman, Benjamin W.

AU - Abdalvand, Ali

PY - 2016

Y1 - 2016

N2 - The aim of this study was to determine if intravenous caffeine is as effective as intravenous ketorolac for the treatment of moderate to severe migraine headaches. Eligible patients randomly received 60 mg caffeine citrate or 60 mg ketorolac infused intravenously. Their pain score were measured at baseline, one hour and two hours after infusion. Therapeutic success was defined as decreasing of at least 3 points on the pain score. In total 110 patients were enrolled (75.5% women). Therapeutic success after 60 min was achieved by 63.6% of patients in the caffeine and 70.1% of patients in the ketorolac group (p = 0.23). After 120 min, 87.3% of the caffeine group and 83.6% of the ketorolac group achieved therapeutic success (p = 0.49). In this multi-center, randomized double blind study, intravenous caffeine was as effective as intravenous ketorolac for first line abortive management of acute migraine.

AB - The aim of this study was to determine if intravenous caffeine is as effective as intravenous ketorolac for the treatment of moderate to severe migraine headaches. Eligible patients randomly received 60 mg caffeine citrate or 60 mg ketorolac infused intravenously. Their pain score were measured at baseline, one hour and two hours after infusion. Therapeutic success was defined as decreasing of at least 3 points on the pain score. In total 110 patients were enrolled (75.5% women). Therapeutic success after 60 min was achieved by 63.6% of patients in the caffeine and 70.1% of patients in the ketorolac group (p = 0.23). After 120 min, 87.3% of the caffeine group and 83.6% of the ketorolac group achieved therapeutic success (p = 0.49). In this multi-center, randomized double blind study, intravenous caffeine was as effective as intravenous ketorolac for first line abortive management of acute migraine.

UR - http://www.scopus.com/inward/record.url?scp=84977558483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977558483&partnerID=8YFLogxK

U2 - 10.3329/bjp.v11i2.26333

DO - 10.3329/bjp.v11i2.26333

M3 - Article

VL - 11

SP - 428

EP - 432

JO - Bangladesh Journal of Pharmacology

JF - Bangladesh Journal of Pharmacology

SN - 1991-007X

IS - 2

ER -